Quantbot Technologies LP Kal Vista Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$8.95 - $11.35 $28,639 - $36,320	3,200 New	3,200 $30,000
Q2 2022 Aug 09, 2022	BUY	$8.16 - $15.1 $28,560 - $52,850	3,500 New	3,500 $34,000
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $24,640 - $37,334	-2,200 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.36 - $18.28 $27,192 - $40,216	2,200 New	2,200 $29,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.